These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 33067726)

  • 21. Prognostic value of preoperative blood-based biomarkers in upper tract urothelial carcinoma treated with nephroureterectomy: A systematic review and meta-analysis.
    Mori K; Janisch F; Mostafaei H; Lysenko I; Kimura S; Egawa S; Shariat SF
    Urol Oncol; 2020 May; 38(5):315-333. PubMed ID: 32088103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Promising role of preoperative neutrophil-to-lymphocyte ratio in patients treated with radical nephroureterectomy.
    Vartolomei MD; Mathieu R; Margulis V; Karam JA; Rouprêt M; Lucca I; Mbeutcha A; Seitz C; Karakiewicz PI; Fajkovic H; Wood CG; Weizer AZ; Raman JD; Rioux-Leclercq N; Haitel A; Bensalah K; Rink M; Briganti A; Xylinas E; Shariat SF
    World J Urol; 2017 Jan; 35(1):121-130. PubMed ID: 27209168
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does neoadjuvant chemotherapy have therapeutic benefit for node-positive upper tract urothelial carcinoma? Results of a multi-center cohort study.
    Shigeta K; Matsumoto K; Ogihara K; Murakami T; Anno T; Umeda K; Izawa M; Baba Y; Sanjo T; Shojo K; Tanaka N; Takeda T; Morita S; Kosaka T; Mizuno R; Arita Y; Akita H; Jinzaki M; Kikuchi E; Oya M
    Urol Oncol; 2022 Mar; 40(3):105.e19-105.e26. PubMed ID: 34454822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase II Trial of Neoadjuvant Systemic Chemotherapy Followed by Extirpative Surgery in Patients with High Grade Upper Tract Urothelial Carcinoma.
    Margulis V; Puligandla M; Trabulsi EJ; Plimack ER; Kessler ER; Matin SF; Godoy G; Alva A; Hahn NM; Carducci MA; Hoffman-Censits J;
    J Urol; 2020 Apr; 203(4):690-698. PubMed ID: 31702432
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The prognostic value of preoperative serum albumin-globulin ratio for high-grade bladder urothelial carcinoma treated with radical cystectomy: A propensity score-matched analysis.
    Liu Z; Huang H; Li S; Yu W; Li W; Jin J; Li X; Xing J
    J Cancer Res Ther; 2017; 13(5):837-843. PubMed ID: 29237914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of neoadjuvant and adjuvant chemotherapy for localized and locally advanced upper tract urothelial carcinoma: a systematic review and meta-analysis.
    Quhal F; Mori K; Sari Motlagh R; Laukhtina E; Pradere B; Rouprêt M; Necchi A; Moschini M; Shariat SF
    Int J Clin Oncol; 2020 Jun; 25(6):1037-1054. PubMed ID: 32206939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preoperative serum pre-albumin as an independent prognostic indicator in patients with localized upper tract urothelial carcinoma after radical nephroureterectomy.
    Huang J; Wang Y; Yuan Y; Chen Y; Kong W; Chen H; Zhang J; Huang Y
    Oncotarget; 2017 May; 8(22):36772-36779. PubMed ID: 27906675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of preoperative serum albumin-globulin ratio on disease outcome after radical cystectomy for urothelial carcinoma of the bladder.
    Schuettfort VM; D Andrea D; Quhal F; Mostafaei H; Laukhtina E; Mori K; Sari Motlagh R; Rink M; Abufaraj M; Karakiewicz PI; Luzzago S; Rouprêt M; Chlosta P; Babjuk M; Deuker M; Moschini M; Shariat SF; Pradere B
    Urol Oncol; 2021 Apr; 39(4):235.e5-235.e14. PubMed ID: 33189530
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pattern and risk factors of local recurrence after nephroureterectomy for upper tract urothelial carcinoma.
    Li X; Cui M; Gu X; Fang D; Li H; Qin S; Yang K; Zhu T; Li X; Zhou L; Gao XS; Wang D
    World J Surg Oncol; 2020 May; 18(1):114. PubMed ID: 32473636
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preoperative C-reactive protein to albumin ratio as a novel prognostic biomarker for the oncological outcomes of radical nephroureterectomy.
    Gwak CH; Suh J; Lim B; Song C; You D; Jeong IG; Hong JH; Hong B; Ahn H
    Urol Oncol; 2024 Feb; 42(2):30.e17-30.e23. PubMed ID: 38072737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platinum-based Neoadjuvant Chemotherapy Improves Oncological Outcomes in Patients with Locally Advanced Upper Tract Urothelial Carcinoma.
    Hosogoe S; Hatakeyama S; Kusaka A; Hamano I; Iwamura H; Fujita N; Yamamoto H; Tobisawa Y; Yoneyama T; Yoneyama T; Hashimoto Y; Koie T; Ohyama C
    Eur Urol Focus; 2018 Dec; 4(6):946-953. PubMed ID: 28753881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contemporary Trends of Systemic Neoadjuvant and Adjuvant Intravesical Chemotherapy in Patients With Upper Tract Urothelial Carcinomas Undergoing Minimally Invasive or Open Radical Nephroureterectomy: Analysis of US Claims on Perioperative Outcomes and Health Care Costs.
    Del Giudice F; van Uem S; Li S; Vilson FL; Sciarra A; Salciccia S; Busetto GM; Maggi M; Tiberia L; Viscuso P; Canale V; Panebianco V; Pecoraro M; Ferro M; Moschini M; Krajewski W; D'Andrea D; Cacciamani GE; Mari A; Soria F; Porpiglia F; Fiori C; Amparore D; Checcucci E; Autorino R; De Berardinis E; Chung BI
    Clin Genitourin Cancer; 2022 Apr; 20(2):198.e1-198.e9. PubMed ID: 35031226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Novel Risk-based Approach Simulating Oncological Surveillance After Radical Nephroureterectomy in Patients with Upper Tract Urothelial Carcinoma.
    Shigeta K; Kikuchi E; Abe T; Hagiwara M; Ogihara K; Anno T; Umeda K; Baba Y; Sanjo T; Shojo K; Mikami S; Mizuno R; Oya M
    Eur Urol Oncol; 2020 Dec; 3(6):756-763. PubMed ID: 31395480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Perioperative chemotherapy in upper tract urothelial carcinoma: a comprehensive review.
    Aziz A; Dobruch J; Hendricksen K; Kluth LA; Necchi A; Noon A; Rink M; Roghmann F; Seiler R; Gontero P; Kassouf W; Shariat SF; Xylinas E;
    World J Urol; 2017 Sep; 35(9):1401-1407. PubMed ID: 28074261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neoadjuvant Chemotherapy in Elderly Patients With Upper Tract Urothelial Cancer: Oncologic Outcomes From a Multicenter Study.
    Grossmann NC; Pradere B; D'Andrea D; Schuettfort VM; Mori K; Rajwa P; Quhal F; Laukhtina E; Katayama S; Fankhauser CD; Xylinas E; Margulis V; Moschini M; Abufaraj M; Bandini M; Lonati C; Nyirady P; Karakiewicz PI; Fajkovic H; Shariat SF
    Clin Genitourin Cancer; 2022 Jun; 20(3):227-236. PubMed ID: 35125303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Caveolin-1 Expression in Upper Tract Urothelial Carcinoma.
    D'Andrea D; Moschini M; Foerster B; Abufaraj M; Margulis V; Karam J; Lotan Y; Raman J; Mathieu R; Rouprêt M; Karakiewicz PI; Briganti A; Haitel A; Shariat SF
    Eur Urol Focus; 2019 Jan; 5(1):97-103. PubMed ID: 28753840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survival effect of perioperative systemic chemotherapy on overall mortality in locally advanced and/or positive regional lymph node non-metastatic urothelial carcinoma of the upper urinary tract.
    Nazzani S; Preisser F; Mazzone E; Tian Z; Mistretta FA; Shariat SF; Soulières D; Saad F; Montanari E; Luzzago S; Briganti A; Carmignani L; Karakiewicz PI
    World J Urol; 2019 Jul; 37(7):1329-1337. PubMed ID: 30298285
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oncological Outcomes of Laparoscopic Nephroureterectomy Versus Open Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: An European Association of Urology Guidelines Systematic Review.
    Peyronnet B; Seisen T; Dominguez-Escrig JL; Bruins HM; Yuan CY; Lam T; Maclennan S; N'dow J; Babjuk M; Comperat E; Zigeuner R; Sylvester RJ; Burger M; Mostafid H; van Rhijn BWG; Gontero P; Palou J; Shariat SF; Roupret M
    Eur Urol Focus; 2019 Mar; 5(2):205-223. PubMed ID: 29154042
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of the preoperative albumin-globulin ratio in patients with upper urinary tract urothelial carcinoma treated with radical nephroureterectomy: results from a large multicenter international collaboration.
    Miura N; Mori K; Laukhtina E; Schuettfort VM; Abufaraj M; Teoh JYC; Luzzago S; Stolzenbach F; Deuker M; Karakiewicz PI; Briganti A; Enikeev DV; Rouprêt M; Margulis V; Chlosta P; Nyirady P; Babjuk M; Egawa S; Saika T; Shariat SF
    Jpn J Clin Oncol; 2021 Jul; 51(7):1149-1157. PubMed ID: 33667307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adjuvant chemotherapy after radical nephroureterectomy improves the survival outcome of high-risk upper tract urothelial carcinoma patients with cardiovascular comorbidity.
    Luo Y; Feng B; Wei D; Han Y; Li M; Zhao J; Lin Y; Hou Z; Jiang Y
    Sci Rep; 2020 Oct; 10(1):17674. PubMed ID: 33077839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.